IDSA GUIDELINES Bundle (free trial)

Influenza

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244261

Contents of this Issue

Navigation

Page 4 of 13

Table 2. Influenza Testing Methods (all A-II) Test Description Methods RT-PCR Time to Results Conventional gel-based real≥2 h time RT-PCR Multiplex PCR Immunoflourescencea DFA staining 2–4 h •  Detects and distinguishes between influenza A and B •  Detects and distinguishes between influenza (A and B) and other respiratory viruses IFA staining •  Detects and distinguishes between influenza A and B •  Detects and distinguishes between influenza (A and B) and other respiratory viruses Rapid influenza Antigen detection: enzyme 10–20 immunoassay diagnostic testsb min •  Detects influenza A only •  Detects, but does not distinguish between, influenza A and B •  Detects and distinguishes between influenza A and B Neuraminidase detection assay 20–30 •  Detects, but does not min distinguish between, influenza A and B Viral culture Shell vial culture 48–72 h Isolation in cell culture 3–10 d Serologyc Hemagglutinin inhibition ELISA Complement-fixation Neutralization Comment High sensitivity, very high specificity; highly recommended Moderately high sensitivity, high specificity; recommended Low to moderate sensitivity, high specificity; limitations should be recognized to interpret results Moderately high sensitivity, highest specificity; important for confirming screening test results and for public health surveillance, but not useful for timely clinical management Available only in reference laboratories, not useful for timely clinical management; recommended only for retrospective diagnosis, surveillance, or research purposes DFA, direct fluorescent antibody; ELISA, enzyme-linked immunosorbent assay; IFA, indirect fluorescent antibody; RT-PCR, reverse transcriptase polymerase chain reaction. a Requires fluorescence microscope. b Includes moderately complex and Clinical Laboratory Improvement Amendments (CLIA)-waived tests. c Usually requires paired acute and convalescent sera. 3

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Influenza